Clinical Trial Update: Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the pharmacokinetics and safety of fexofenadine in healthy adults who are slow metabolizers of desloratadine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Desloratadine (desloratadine)
• Fexofenadine (fexofenadine)

Snippet

Sponsor: Sanofi | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED